Location: Boston, MA
CIK: 0001816307 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 13, 2022
Total Value: $242M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ATHIRA PHARMA INC | 10,000 | $26.96M | 11.2% | $2696.40 | — | COM | 04746L104 |
| XBI | SPDR SER TR | 300,000 | $26.96M | 11.2% | — | — | Call | 78464A870 |
| — | INTRA-CELLULAR THERAPIES INC | 308,819 | $18.9M | 7.8% | $48.82 | — | COM | 46116X101 |
| — | SIERRA ONCOLOGY INC | 443,381 | $14.21M | 5.9% | $25.84 | — | COM NEW | 82640U404 |
| VCYT | VERACYTE INC | 425,554 | $11.73M | 4.9% | $38.26 | -25.2% | COM | 92337F107 |
| — | CTI BIOPHARMA CORP | 2,250,000 | $10.51M | 4.3% | $3.23 | — | COM | 12648L601 |
| — | MERUS N V | 324,719 | $8.586M | 3.6% | $21.09 | — | COM | N5749R100 |
| CERS | CERUS CORP | 1,398,400 | $7.677M | 3.2% | $6.03 | -8.2% | COM | 157085101 |
| — | HORIZON THERAPEUTICS PUB L | 67,442 | $7.096M | 2.9% | $87.59 | — | SHS | G46188101 |
| — | APOLLO ENDOSURGERY INC | 1,004,399 | $6.077M | 2.5% | $7.80 | — | COM | 03767D108 |
| APLS | APELLIS PHARMACEUTICALS INC | 105,368 | $5.354M | 2.2% | $44.15 | 0.0% | COM | 03753U106 |
| ACRS | ACLARIS THERAPEUTICS INC | 275,333 | $4.747M | 2.0% | $17.82 | -23.4% | COM | 00461U105 |
| — | ITEOS THERAPEUTICS INC | 138,843 | $4.468M | 1.8% | $29.25 | — | COM | 46565G104 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 102,497 | $4.359M | 1.8% | $83.53 | — | COM | G11196105 |
| COGT | COGENT BIOSCIENCES INC | 573,699 | $4.297M | 1.8% | $8.41 | -17.2% | COM | 19240Q201 |
| — | MIRATI THERAPEUTICS INC | 46,122 | $3.792M | 1.6% | $164.76 | — | COM | 60468T105 |
| IMTX | IMMATICS N.V | 445,334 | $3.558M | 1.5% | $11.68 | -22.0% | SHS | N44445109 |
| KRYS | KRYSTAL BIOTECH INC | 46,489 | $3.093M | 1.3% | $58.21 | +7.2% | COM | 501147102 |
| — | IMMUNOGEN INC | 645,000 | $3.07M | 1.3% | $7.12 | — | COM | 45253H101 |
| — | NGM BIOPHARMACEUTICALS INC | 200,494 | $3.058M | 1.3% | $15.25 | — | COM | 62921N105 |
| — | OTONOMY INC | 1,207,385 | $2.898M | 1.2% | $3.08 | — | COM | 68906L105 |
| — | MORPHIC HLDG INC | 68,709 | $2.759M | 1.1% | $46.15 | — | COM | 61775R105 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 14,836 | $2.662M | 1.1% | $177.53 | +7.3% | COM | 91307C102 |
| GLPG | GALAPAGOS NV | 41,002 | $2.543M | 1.1% | $55.13 | — | SPON ADR | 36315X101 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 114,004 | $2.502M | 1.0% | $22.95 | -11.8% | COM | 22663K107 |
| INSM | INSMED INC | 102,067 | $2.399M | 1.0% | $36.48 | -36.3% | COM PAR $.01 | 457669307 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 126,136 | $2.332M | 1.0% | $16.21 | +18.5% | COM | 92790C104 |
| — | SERES THERAPEUTICS INC | 326,872 | $2.327M | 1.0% | $10.01 | — | COM | 81750R102 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 185,666 | $2.256M | 0.9% | $11.87 | -7.7% | COM NEW | 30233G209 |
| VRTX | VERTEX PHARMACEUTICALS INC | 7,638 | $1.993M | 0.8% | $209.26 | +13.4% | COM | 92532F100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 20,482 | $1.92M | 0.8% | $84.75 | 0.0% | COM | 64125C109 |
| — | LEAP THERAPEUTICS INC | 1,032,163 | $1.806M | 0.7% | $3.68 | — | COM | 52187K101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 101,447 | $1.763M | 0.7% | $18.45 | -8.8% | COM | 87164F105 |
| VRAYQ | VIEWRAY INC | 436,096 | $1.709M | 0.7% | $5.94 | -28.3% | COM | 92672L107 |
| — | JOUNCE THERAPEUTICS INC | 248,347 | $1.686M | 0.7% | $7.20 | — | COM | 481116101 |
| CDXS | CODEXIS INC | 81,000 | $1.67M | 0.7% | $20.71 | 0.0% | COM | 192005106 |
| — | POINT BIOPHARMA GLOBAL INC | 204,679 | $1.631M | 0.7% | $6.34 | — | COM | 730541109 |
| — | FORMA THERAPEUTICS HLDGS INC | 174,768 | $1.625M | 0.7% | $9.30 | — | SHS | 34633R104 |
| — | ASLAN PHARMACEUTICALS LTD | 500,000 | $1.592M | 0.7% | $1.12 | — | ADS | 04522R101 |
| — | IVERIC BIO INC | 94,600 | $1.592M | 0.7% | — | — | Put | 46583P102 |
| — | SEAGEN INC | 10,956 | $1.578M | 0.7% | $171.32 | — | COM | 81181C104 |
| XENE | XENON PHARMACEUTICALS INC | 101,081 | $1.428M | 0.6% | $27.48 | +8.9% | COM | 98420N105 |
| ASND | ASCENDIS PHARMA A/S | 25,000 | $1.428M | 0.6% | $57.12 | — | SPONSORED ADR | 04351P101 |
| — | IMMUNOGEN INC | 300,000 | $1.428M | 0.6% | $7.12 | — | Call | 45253H101 |
| — | CYCLACEL PHARMACEUTICALS INC | 462,659 | $1.411M | 0.6% | $6.08 | — | COM | 23254L603 |
| STXS | STEREOTAXIS INC | 346,405 | $1.292M | 0.5% | $7.60 | -37.9% | COM NEW | 85916J409 |
| — | MEDICUS SCIENCES ACQUISITION | 131,151 | $1.283M | 0.5% | $9.66 | — | CL A SHS | G5960S108 |
| — | AMRYT PHARMA PLC | 153,267 | $1.268M | 0.5% | $13.80 | — | SPONSORED ADS | 03217L106 |
| — | POLYPID LTD | 218,175 | $1.191M | 0.5% | $8.42 | — | SHS | M8001Q118 |
| — | LUCIRA HEALTH INC | 310,734 | $1.109M | 0.5% | $8.18 | — | COM | 54948U105 |
| — | ELOXX PHARMACEUTICALS INC | 1,950,949 | $1.092M | 0.5% | $1.53 | — | COM | 29014R103 |
| — | POSEIDA THERAPEUTICS INC | 239,696 | $1.074M | 0.4% | $6.76 | — | COM | 73730P108 |
| — | NEXTCURE INC | 196,187 | $953K | 0.4% | $7.21 | — | COM | 65343E108 |
| CGEN | COMPUGEN LTD | 268,596 | $865K | 0.4% | $7.48 | -54.9% | ORD | M25722105 |
| IMUX | IMMUNIC INC | 68,475 | $774K | 0.3% | $11.58 | 0.0% | COM | 4525EP101 |
| CLYM | ELIEM THERAPEUTICS INC | 88,279 | $741K | 0.3% | $9.33 | 0.0% | COM | 28658R106 |
| — | APTINYX INC | 201,600 | $458K | 0.2% | — | — | Put | 03836N103 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 30,000 | $386K | 0.2% | $22.45 | 0.0% | COM | 03237H101 |
| — | EVOGENE LTD | 295,746 | $384K | 0.2% | $4.20 | — | SHS | M4119S104 |
| MREO | MEREO BIOPHARMA GROUP PLC | 235,515 | $264K | 0.1% | $3.32 | — | ADS | 589492107 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 45,538 | $256K | 0.1% | $42.13 | -24.1% | COM NEW | 15117B202 |
| BIIB | BIOGEN INC | 10,248 | $230K | 0.1% | $269.94 | -19.4% | COM | 09062X103 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 102,425 | $197K | 0.1% | $16.04 | 0.0% | COM | 09058V103 |
| — | BELLUS HEALTH INC NEW | 1,235,784 | $177K | 0.1% | $6.10 | — | COM NEW | 07987C204 |
| — | CALITHERA BIOSCIENCES INC | 221,809 | $74,000 | 0.0% | $2.15 | — | COM | 13089P101 |
| — | BENITEC BIOPHARMA INC | 492,880 | $57,000 | 0.0% | $3.97 | — | COM | 08205P100 |
| — | RENOVACOR INC | 104,828 | $33,000 | 0.0% | $0.40 | — | *W EXP 99/99/999 | 75989E114 |
| — | ALIGOS THERAPEUTICS INC | 10,659 | $23,000 | 0.0% | $2.16 | — | COM | 01626L105 |
| — | MEDICUS SCIENCES ACQUISITION | 49,990 | $21,000 | 0.0% | $1.00 | — | *W EXP 02/12/202 | G5960S124 |